Clinical Trials

Ototoxicity, Mucositis

NCT05966194 2024-11-15

KEVLARx

Phase 2 Recruiting

216 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03515538 2024-11-04

PREVLAR

53 enrolled 15 charts

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03417765 2024-10-24

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

Phase 1/2 Withdrawn

LymphoidOther

Hodgkin Disease, Lymphoma, Mucositis

NCT04046250 2023-08-25

TK112690

22 enrolled 10 charts

Head and Neck Neoplasms, Mucositis

NCT05658016 2023-08-14

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

Phase 2 Unknown

24 enrolled

Head and Neck Neoplasms, Mucositis

NCT05669521 2023-08-14

Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690

Phase 2 Unknown

24 enrolled

GastrointestinalOther

Colorectal Neoplasms, Mucositis

NCT04648020 2023-05-31

VOICE

Phase 2/3 Terminated

190 enrolled

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Stomatitis, Oral Ulcer, Mucositis

NCT02990468 2023-03-15

BMX-HN

Phase 1/2 Completed

29 enrolled 14 charts

Head and Neck Neoplasms, Xerostomia, Mucositis

NCT02606994 2019-02-06

TPvsM

Phase 2 Terminated

1 enrolled

Neoplasms, Stomatitis, Mucositis

NCT02324335 2019-01-16

Brilacidin

61 enrolled 12 charts

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT02885376 2018-12-21

Study of Dentoxol® Mouthrinse for Oral Mucositis

108 enrolled

Stomatitis, Mucositis

NCT02630004 2018-03-01

MUCOMEL

Phase 1/2 Completed

84 enrolled

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Phase 3 Completed

188 enrolled 19 charts

OtherOther hematologic neoplasm

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

NCT01554254 2016-08-31

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Phase 2 Withdrawn

Hematologic Neoplasms, Mucositis

NCT01882374 2016-08-31

Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation

Phase 2 Withdrawn

OtherOther hematologic neoplasm

Hematologic Neoplasms, Mucositis

NCT01882387 2016-08-31

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Phase 2 Withdrawn

OtherOther hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms, Mucositis

NCT00070616 2014-10-24

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

Phase 1 Completed

25 enrolled

LymphoidOtherOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Mucositis, Neoplasms, Plasma Cell

NCT01283906 2013-09-12

MuGard

Phase 4 Completed

120 enrolled

Head and Neck Neoplasms, Stomatitis, Neoplasms, Squamous Cell, Mucositis

NCT00956254 2013-09-05

Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis

Phase 3 Completed

18 enrolled 6 charts

Pain, Mucositis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

110 enrolled